Cargando…

Clinicopathological Characteristics of Estrogen Receptor‐(3‐positive Human Breast Cancers

Recent studies have identified the presence of estrogen receptor (ER)‐β in addition to ER‐α in human breast cancers, but the Clinicopathological characteristics of ER‐β‐positive tumors remain to be established. In this study, we have conducted an immunohistochemical analysis of ER‐α and ER‐β express...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyoshi, Yasuo, Taguchi, Tetsuya, Gustafsson, Jan‐Åke, Noguchi, Shinzaburo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2001
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926611/ https://www.ncbi.nlm.nih.gov/pubmed/11676856 http://dx.doi.org/10.1111/j.1349-7006.2001.tb01060.x

Ejemplares similares

Quantitative Analysis of BRCA1 and BRCA2 mRNA Expression in Sporadic Breast Carcinomas and Its Relationship with Clinicopathological Characteristics
por: Egawa, Chiyomi, et al.
Publicado: (2001)

Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC)
por: Nakayama, Takahiro, et al.
Publicado: (2018)

Influence of Tamoxifen‐Medroxyprogesterone Sequential Therapy on Estrogen and Progesterone Receptor Contents of Breast Cancer
por: Noguchi, Shinzaburo, et al.
Publicado: (1989)

Estrogen receptor transcription and transactivation: Basic aspects of estrogen action
por: Nilsson , Stefan, et al.
Publicado: (2000)

Radiogenomics of magnetic resonance imaging and a new multi-gene classifier for predicting recurrence prognosis in estrogen receptor-positive breast cancer: A preliminary study
por: Tokuda, Yukiko, et al.
Publicado: (2020)

Endocrine sensitivity of estrogen receptor‐positive breast cancer is negatively correlated with aspartate‐β‐hydroxylase expression
por: Shimoda, Masafumi, et al.
Publicado: (2017)

Estrogen receptor and aryl hydrocarbon receptor signaling pathways
por: Matthews, Jason, et al.
Publicado: (2006)

Estrogen receptor β: an overview and update
por: Zhao, Chunyan, et al.
Publicado: (2008)

Prognostic Significance of Occult Bone Marrow Micrometastases of Breast Cancer Detected by Quantitative Polymerase Chain Reaction for Cytokeratin 19 mRNA
por: Ikeda, Noriko, et al.
Publicado: (2000)

Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer
por: Noguchi, Shinzaburo, et al.
Publicado: (2015)

Characteristics and Prognosis of Estrogen Receptor Low-Positive Breast Cancer
por: Kim, Min Chong, et al.
Publicado: (2022)

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer
por: Miyoshi, Yuichiro, et al.
Publicado: (2019)

Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor–positive breast cancer
por: Chen, Weilin, et al.
Publicado: (2023)

Estrogen-Related Receptors Gene Expression and Copy Number Alteration Association With the Clinicopathologic Characteristics of Breast Cancer
por: Shatnawi, Aymen, et al.
Publicado: (2022)

Cardiovascular roles of estrogen receptors: insights gained from knockout models
por: Otsuki, Michio, et al.
Publicado: (2003)

The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer
por: Korzets, Yasmin, et al.
Publicado: (2021)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis
por: Bado, Igor, et al.
Publicado: (2017)

Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces Cancer Stem Cells in Triple Negative Breast Cancer
por: Bano, Ayesha, et al.
Publicado: (2023)

Effects of two common polymorphisms in the 3' untranslated regions of estrogen receptor β on mRNA stability and translatability
por: Putnik, Milica, et al.
Publicado: (2009)

Liver X receptors and estrogen receptor β, two players in a rare subtype of NSCLC
por: Wu, Wanfu, et al.
Publicado: (2023)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
por: Kim, Min Chong, et al.
Publicado: (2023)

Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity
por: Lindberg, Karolina, et al.
Publicado: (2011)

Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines
por: Rizza, Pietro, et al.
Publicado: (2014)

Estrogen receptor β2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1α
por: Bialesova, Lucia, et al.
Publicado: (2017)

Clinical characteristics and survival outcome of patients with estrogen receptor low positive breast cancer
por: Luo, Chuanxu, et al.
Publicado: (2022)

Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2013)

Clinicopathological Characteristics and Breast Cancer–Specific Survival of Patients With Single Hormone Receptor–Positive Breast Cancer
por: Li, Yunhai, et al.
Publicado: (2020)

Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
por: Amanatullah, Derek F., et al.
Publicado: (2017)

The multigene classifiers 95GC/42GC/155GC for precision medicine in ER‐positive HER2‐negative early breast cancer
por: Naoi, Yasuto, et al.
Publicado: (2021)

The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling
por: Faria, Michelle, et al.
Publicado: (2018)

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2019)

Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
por: Agrawal, Anil, et al.
Publicado: (2016)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Antidiabetic Actions of an Estrogen Receptor β Selective Agonist
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2013)

Mouse models of estrogen receptor-positive breast cancer
por: Mohibi, Shakur, et al.
Publicado: (2011)

Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
por: Porras, Lucas, et al.
Publicado: (2021)

Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity
por: Chaurasiya, Surendra, et al.
Publicado: (2020)

Memo interacts with c-Src to control Estrogen Receptor alpha sub-cellular localization
por: Frei, Anna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mkpbevaeoflaehkf9qgjlgffrm